2
RESEARCH METHODOLOGY
43
5
MARKET OVERVIEW
Emerging markets and advanced tech drive neuromodulation growth despite cost and regulatory hurdles.
63
5.2.1.1
Rising prevalence of neurological disorders and nerve injuries
5.2.1.2
High incidence of neurological disorders among geriatric population
5.2.1.3
Favorable government support and funding with advanced healthcare infrastructure
5.2.1.4
Development of advanced neuromodulation and neurostimulation technologies
5.2.1.5
Growing collaborations among device manufacturers, healthcare providers, and research institutions
5.2.1.6
Availability of reimbursements for neuromodulation devices
5.2.2.1
High cost of neuromodulation procedures
5.2.2.2
Preference for drug therapies over neuromodulation products
5.2.2.3
Adverse effects and complications with neuromodulation devices
5.2.3.1
Large population and high healthcare expenditure in emerging economies
5.2.3.2
Widening application scope of neuromodulation
5.2.4.1
Stringent regulatory framework and time-consuming approval processes for neuromodulation and neurostimulation devices
5.2.4.2
Shortage of trained professionals
5.3
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.4.1
AVERAGE SELLING PRICE TREND OF NEUROMODULATION PRODUCTS, BY STIMULATION TYPE, 2023–2025
5.4.2
AVERAGE SELLING PRICE TREND OF NEUROMODULATION PRODUCTS, BY KEY PLAYER, 2023–2025
5.4.3
AVERAGE SELLING PRICE TREND OF NEUROMODULATION PRODUCTS, BY REGION, 2023–2025
5.6
SUPPLY CHAIN ANALYSIS
5.8
INVESTMENT & FUNDING SCENARIO
5.9.1.1
Transcutaneous electrical nerve stimulation
5.9.2
COMPLEMENTARY TECHNOLOGIES
5.9.2.1
Wearable biosensors
5.9.3
ADJACENT TECHNOLOGIES
5.9.3.1
Regenerative medicine and stem cells
5.10.1
LIST OF KEY PATENTS
5.11.1
IMPORT DATA FOR HS CODE 901890
5.11.2
EXPORT DATA FOR HS CODE 901890
5.12
KEY CONFERENCES & EVENTS, 2025–2026
5.13.1
USE OF NEURALMODULATION TECHNOLOGIES IN RESEARCH, CLINICAL PRACTICE, AND CONSUMER APPLICATIONS
5.13.2
PAIRING TRANSLINGUAL NEUROSTIMULATION WITH INTENSIVE REHABILITATION TO ENHANCE NEUROPLASTICITY AND IMPROVE MOTOR RECOVERY IN SEVERE TRAUMATIC BRAIN INJURY PATIENTS
5.13.3
APPLICATION OF NEUROMODULATION TECHNIQUES—FROM NON-INVASIVE BRAIN STIMULATION TO DEEP BRAIN STIMULATION
5.14.1
REGULATORY LANDSCAPE
5.14.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.15
PORTER’S FIVE FORCES ANALYSIS
5.15.1
BARGAINING POWER OF SUPPLIERS
5.15.2
BARGAINING POWER OF BUYERS
5.15.3
THREAT OF NEW ENTRANTS
5.15.4
THREAT OF SUBSTITUTES
5.15.5
INTENSITY OF COMPETITIVE RIVALRY
5.16
KEY STAKEHOLDERS & BUYING CRITERIA
5.16.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.16.2
KEY BUYING CRITERIA
5.17
IMPACT OF AI/GEN AI ON NEUROMODULATION MARKET
5.17.4
KEY COMPANIES IMPLEMENTING AI
5.18
IMPACT OF 2025 US TARIFF ON NEUROMODULATION MARKET
5.18.3
PRICE IMPACT ANALYSIS
5.18.4
IMPACT ON COUNTRY/REGION
5.18.5
IMPACT ON END-USE INDUSTRIES
6
NEUROMODULATION MARKET, BY TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 11 Data Tables
98
6.2
INTERNAL NEUROMODULATION
6.2.1
INTERNAL NEUROMODULATION TO RESULT IN BETTER TREATMENT RESULTS AND LOWER HEALTHCARE COSTS
6.3
EXTERNAL NEUROMODULATION
6.3.1
RISING DEMAND FOR NON-INVASIVE SOLUTIONS FOR NEUROLOGICAL AND PAIN-RELATED DISORDERS TO FUEL GROWTH
7
NEUROMODULATION MARKET, BY STIMULATION TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 55 Data Tables
105
7.2
SPINAL CORD STIMULATION
7.2.1
GROWING INCIDENCE OF SPINAL CORD INJURIES TO FUEL MARKET GROWTH
7.3
DEEP BRAIN STIMULATION
7.3.1
MINIMALLY INVASIVE DEEP BRAIN STIMULATION TO DELIVER CONTROLLED ELECTRICAL IMPULSES AND REDUCE SIDE EFFECTS
7.4
SACRAL NERVE STIMULATION
7.4.1
INCREASING PREVALENCE OF CHRONIC URINARY INCONTINENCE AMONG ELDERLY WOMEN TO PROPEL MARKET GROWTH
7.5
VAGUS NERVE STIMULATION
7.5.1
RISING INCIDENCE OF EPILEPSY TO DRIVE ADOPTION OF NEXT-GENERATION VAGUS NERVE STIMULATION THERAPY
7.6
GASTRIC NERVE STIMULATION
7.6.1
INCREASING PREVALENCE OF GASTROESOPHAGEAL REFLUX DISEASE AND GASTROPARESIS TO FUEL MARKET GROWTH
7.7
TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION
7.7.1
LOW COST AND EASE OF USE TO FUEL ADOPTION IN HEALTHCARE SECTOR
7.8
TRANSCRANIAL MAGNETIC STIMULATION
7.8.1
MINIMAL PATIENT DISCOMFORT ASSOCIATED WITH TRANSCRANIAL MAGNETIC STIMULATION TO SUPPORT DEMAND
7.9
RESPIRATORY ELECTRICAL STIMULATION
7.9.1
HIGH TREATMENT EFFICACY AND INCREASED FOCUS ON MINIMALLY INVASIVE SPINAL CORD TREATMENT TO FUEL MARKET GROWTH
7.10
OTHER STIMULATION TYPES
8
NEUROMODULATION MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 103 Data Tables
135
8.2
NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION
8.2.1.1
High incidence of chronic pain among geriatric population to support market growth
8.2.2
FAILED BACK SURGERY SYNDROME
8.2.2.1
Increasing number of spinal surgeries to aid market growth
8.2.3.1
High effectiveness of neuromodulation to boost effectiveness for ischemia treatment
8.3
NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION
8.3.1
PARKINSON’S DISEASE
8.3.1.1
Development of advanced solutions and increased R&D to improve market growth
8.3.2.1
Increased prevalence of tremors and high efficacy of deep brain stimulation to drive market
8.3.3.1
Ongoing research and clinical studies to boost adoption of deep brain stimulation for depression treatment
8.3.4
OTHER DEEP BRAIN STIMULATION APPLICATIONS
8.4
NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION
8.4.1.1
High incidence of urine incontinence to offer growth opportunities for market players
8.4.2.1
Reduced symptom recurrence with sacral nerve stimulation to aid long-term management of fecal incontinence
8.5
NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION
8.5.1.1
Low risk with device implantation and long-lasting battery life to aid market growth
8.5.2
OTHER VAGUS NERVE STIMULATION APPLICATIONS
8.6
NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION
8.6.1.1
Reduced hospitalization time associated with sastroparesis treatment to augment market growth
8.6.2.1
High prevalence of obesity and risks associated with gastric bypass to propel market growth
8.7
NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION
8.7.1
TREATMENT-RESISTANT DEPRESSION
8.7.1.1
High prevalence of chronic and recurrent depression to augment market growth
8.7.2
OTHER TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION APPLICATIONS
8.8
NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION
8.8.1.1
Repeated transcranial magnetic stimulation to be well-tolerated procedure with improved acceptance among patients
8.8.2.1
High prevalence of migraines to support market growth
8.9
NEUROMODULATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION, BY APPLICATION
8.9.1
INCREASING INCIDENCE OF SPINAL CORD INJURIES TO ENSURE CONTINUED DEMAND FOR ADVANCED TREATMENT OPTIONS
9
NEUROMODULATION MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 17 Data Tables
189
9.2
HOSPITALS & AMBULATORY SURGERY CENTERS
9.2.1
ADVANCED INFRASTRUCTURE AND ABILITY TO MANAGE COMPLEX NEUROLOGICAL CASES TO PROPEL MARKET GROWTH
9.3
CLINICS & PHYSIOTHERAPY CENTERS
9.3.1
NEED FOR FOCUSED EXPERTISE AND BETTER REHABILITATION MANAGEMENT TO ACCELERATE MARKET EXPANSION
10
NEUROMODULATION MARKET, BY REGION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 230 Data Tables
199
10.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2.1
US to dominate North American neuromodulation market during forecast period
10.2.3.1
Increasing neurological disorder rates and rising government funding to propel market growth
10.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2.1
Advanced surgical innovations and favorable reimbursement policies to drive market
10.3.3.1
Favorable healthcare reforms to drive adoption of advanced neuromodulation techniques
10.3.4.1
Increased public & private sector healthcare expenditure and investments to fuel market growth
10.3.5.1
Rising cases of dementia and Alzheimer’s among geriatric population to spur market growth
10.3.6.1
Favorable government-led healthcare initiatives to support market growth
10.3.7.1
Shifting demographic landscape and escalating neurological health needs to drive demand
10.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2.1
Government-led healthcare reforms and high prevalence of neurological disorders to fuel demand
10.4.3.1
Innovative healthcare delivery and advanced infrastructure landscape to augment market growth
10.4.4.1
Booming medical tourism and rising middle class with higher disposable incomes to accelerate market growth
10.4.5.1
Increasing cases of depressive and post-traumatic stress disorders to propel market demand
10.4.6
REST OF ASIA PACIFIC
10.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2.1
Improvements in healthcare infrastructure to aid market growth
10.5.3.1
Expanding healthcare awareness and growing burden of neurological disorders to favor market growth
10.5.4
REST OF LATIN AMERICA
10.6
MIDDLE EAST & AFRICA
10.6.1
IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE AND INCREASED AWARENESS OF NEUROLOGICAL CARE TO DRIVE MARKET
10.6.2
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
11
COMPETITIVE LANDSCAPE
Discover top strategies and market positions driving neuromodulation's competitive edge.
297
11.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NEUROMODULATION MARKET
11.3
REVENUE ANALYSIS, 2020–2024
11.4
MARKET SHARE ANALYSIS, 2024
11.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.5.5.1
Company footprint
11.5.5.2
Region footprint
11.5.5.3
Technology footprint
11.5.5.4
Stimulation type footprint
11.5.5.5
End-user footprint
11.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
11.6.1
PROGRESSIVE COMPANIES
11.6.2
RESPONSIVE COMPANIES
11.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
11.6.5.1
Detailed list of key startups/SMEs
11.6.5.2
Competitive benchmarking of startups/SMEs
11.7
COMPANY VALUATION & FINANCIAL METRICS
11.8
BRAND/PRODUCT COMPARISON
11.9
COMPETITIVE SCENARIO
11.9.1
PRODUCT LAUNCHES & APPROVALS
12
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
314
12.1.1.1
Business overview
12.1.1.2
Products offered
12.1.1.3
Recent developments
12.1.2
BOSTON SCIENTIFIC CORPORATION
12.1.9
HELIUS MEDICAL TECHNOLOGIES, INC.
12.2.2
SOTERIX MEDICAL INC.
12.2.3
SYNAPSE BIOMEDICAL INC.
12.2.4
ALEVA NEUROTHERAPEUTICS
12.2.5
THERANICA BIO-ELECTRONICS LTD.
12.2.7
NALU MEDICAL, INC.
12.2.8
MICROTRANSPONDER INC.
12.2.10
AMBER THERAPEUTICS
12.2.11
TVNS TECHNOLOGIES GMBH
12.2.14
SALUDA MEDICAL PTY LTD.
13.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3
CUSTOMIZATION OPTIONS
TABLE 1
NEUROMODULATION MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2
NEUROMODULATION MARKET: KEY DATA FROM PRIMARY SOURCES
TABLE 3
MARKET ASSUMPTIONS IN NEUROMODULATION MARKET
TABLE 4
RISK ANALYSIS IN NEUROMODULATION MARKET
TABLE 5
POTENTIAL ADVERSE EFFECTS ASSOCIATED WITH DIFFERENT NEUROMODULATION DEVICES
TABLE 6
AVERAGE SELLING PRICING TREND OF NEUROMODULATION PRODUCTS, BY STIMULATION TYPE, 2023–2025 (USD)
TABLE 7
AVERAGE SELLING PRICE TREND OF NEUROMODULATION PRODUCTS, BY KEY PLAYER, 2023–2025 (USD)
TABLE 8
AVERAGE SELLING PRICE TREND OF NEUROMODULATION PRODUCTS, BY REGION, 2023–2025 (USD)
TABLE 9
ROLE OF KEY PLAYERS IN ECOSYSTEM (SUPPLY AND DEMAND SIDES)
TABLE 10
LIST OF KEY PATENTS IN NEUROMODULATION MARKET, 2022–2025
TABLE 11
IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 12
EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 13
LIST OF KEY CONFERENCES & EVENTS IN NEUROMODULATION MARKET, JANUARY 2025–DECEMBER 2026
TABLE 14
CLASSIFICATION OF MEDICAL DEVICES BY US FDA
TABLE 15
NATIONAL MEDICAL PRODUCT ADMINISTRATION (NMPA) MEDICAL DEVICES CLASSIFICATION
TABLE 16
JAPAN: CLASSIFICATION OF MEDICAL DEVICES
TABLE 17
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22
IMPACT OF PORTER’S FIVE FORCES ON NEUROMODULATION MARKET
TABLE 23
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER (%)
TABLE 24
KEY BUYING CRITERIA, BY END USER
TABLE 25
KEY COMPANIES IMPLEMENTING AI IN NEUROMODULATION MARKET
TABLE 26
US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 27
NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 28
INTERNAL NEUROMODULATION MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 29
NORTH AMERICA: INTERNAL NEUROMODULATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 30
EUROPE: INTERNAL NEUROMODULATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 31
ASIA PACIFIC: INTERNAL NEUROMODULATION MARKET, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 32
LATIN AMERICA: INTERNAL NEUROMODULATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 33
EXTERNAL NEUROMODULATION MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 34
NORTH AMERICA: EXTERNAL NEUROMODULATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 35
EUROPE: EXTERNAL NEUROMODULATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 36
ASIA PACIFIC: EXTERNAL NEUROMODULATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 37
LATIN AMERICA: EXTERNAL NEUROMODULATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 38
NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 39
SPINAL CORD STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 40
NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY REGION, 2023–2030 (USD MILLION)
TABLE 41
NORTH AMERICA: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 42
EUROPE: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 43
ASIA PACIFIC: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 44
LATIN AMERICA: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 45
DEEP BRAIN STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 46
NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY REGION, 2023–2030 (USD MILLION)
TABLE 47
NORTH AMERICA: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 48
EUROPE: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 49
ASIA PACIFIC: NEUROMODULATION FOR DEEP BRAIN STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 50
LATIN AMERICA: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 51
SACRAL NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 52
NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY REGION, 2023–2030 (USD MILLION)
TABLE 53
NORTH AMERICA: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 54
EUROPE: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 55
ASIA PACIFIC: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 56
LATIN AMERICA: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 57
VAGUS NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 58
NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY REGION, 2023–2030 (USD MILLION)
TABLE 59
NORTH AMERICA: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 60
EUROPE: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 61
ASIA PACIFIC: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 62
LATIN AMERICA: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 63
GASTRIC NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 64
NEUROMODULATION MARKET FOR GASTRIC NERVE STIMULATION, BY REGION, 2023–2030 (USD MILLION)
TABLE 65
NORTH AMERICA: NEUROMODULATION MARKET FOR GASTRIC NERVE STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 66
EUROPE: NEUROMODULATION MARKET FOR GASTRIC NERVE STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 67
ASIA PACIFIC: NEUROMODULATION MARKET FOR GASTRIC NERVE STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 68
LATIN AMERICA: NEUROMODULATION MARKET FOR GASTRIC NERVE STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 69
TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 70
NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY REGION, 2023–2030 (USD MILLION)
TABLE 71
NORTH AMERICA: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 72
EUROPE: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 73
ASIA PACIFIC: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 74
LATIN AMERICA: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 75
TRANSCRANIAL MAGNETIC STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 76
NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY REGION, 2023–2030 (USD MILLION)
TABLE 77
NORTH AMERICA: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 78
EUROPE: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 79
ASIA PACIFIC: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 80
LATIN AMERICA: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 81
RESPIRATORY ELECTRICAL STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 82
NEUROMODULATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION, BY REGION, 2023–2030 (USD MILLION)
TABLE 83
NORTH AMERICA: NEUROMODULATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 84
EUROPE: NEUROMODULATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 85
ASIA PACIFIC: NEUROMODULATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 86
LATIN AMERICA: NEUROMODULATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 87
OTHER STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 88
NEUROMODULATION MARKET FOR OTHER STIMULATION TYPES, BY REGION, 2023–2030 (USD MILLION)
TABLE 89
NORTH AMERICA: NEUROMODULATION MARKET FOR OTHER STIMULATION TYPES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 90
EUROPE: NEUROMODULATION MARKET FOR OTHER STIMULATION TYPES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 91
ASIA PACIFIC: NEUROMODULATION MARKET FOR OTHER STIMULATION TYPES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 92
LATIN AMERICA: NEUROMODULATION MARKET FOR OTHER STIMULATION TYPES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 93
NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 94
SPINAL CORD STIMULATION MARKET FOR CHRONIC PAIN, BY REGION, 2023–2030 (USD MILLION)
TABLE 95
NORTH AMERICA: SPINAL CORD STIMULATION MARKET FOR CHRONIC PAIN, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 96
EUROPE: SPINAL CORD STIMULATION MARKET FOR CHRONIC PAIN, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 97
ASIA PACIFIC: SPINAL CORD STIMULATION MARKET FOR CHRONIC PAIN, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 98
LATIN AMERICA: SPINAL CORD STIMULATION MARKET FOR CHRONIC PAIN, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 99
SPINAL CORD STIMULATION MARKET FOR FAILED BACK SURGERY SYNDROME, BY REGION, 2023–2030 (USD MILLION)
TABLE 100
NORTH AMERICA: SPINAL CORD STIMULATION MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 101
EUROPE: SPINAL CORD STIMULATION MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 102
ASIA PACIFIC: SPINAL CORD STIMULATION MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 103
LATIN AMERICA: SPINAL CORD STIMULATION MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 104
SPINAL CORD STIMULATION MARKET FOR ISCHEMIA, BY REGION, 2023–2030 (USD MILLION)
TABLE 105
NORTH AMERICA: SPINAL CORD STIMULATION MARKET FOR ISCHEMIA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 106
EUROPE: SPINAL CORD STIMULATION MARKET FOR ISCHEMIA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 107
ASIA PACIFIC: SPINAL CORD STIMULATION MARKET FOR ISCHEMIA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 108
LATIN AMERICA: SPINAL CORD STIMULATION MARKET FOR ISCHEMIA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 109
NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 110
DEEP BRAIN STIMULATION MARKET FOR PARKINSON’S DISEASE, BY REGION, 2023–2030 (USD MILLION)
TABLE 111
NORTH AMERICA: DEEP BRAIN STIMULATION MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 112
EUROPE: DEEP BRAIN STIMULATION MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 113
ASIA PACIFIC: DEEP BRAIN STIMULATION MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 114
LATIN AMERICA: DEEP BRAIN STIMULATION MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 115
DEEP BRAIN STIMULATION MARKET FOR TREMORS, BY REGION, 2023–2030 (USD MILLION)
TABLE 116
NORTH AMERICA: DEEP BRAIN STIMULATION MARKET FOR TREMORS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 117
EUROPE: DEEP BRAIN STIMULATION MARKET FOR TREMORS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 118
ASIA PACIFIC: DEEP BRAIN STIMULATION MARKET FOR TREMORS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 119
LATIN AMERICA: DEEP BRAIN STIMULATION MARKET FOR TREMORS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 120
DEEP BRAIN STIMULATION MARKET FOR DEPRESSION, BY REGION, 2023–2030 (USD MILLION)
TABLE 121
NORTH AMERICA: DEEP BRAIN STIMULATION MARKET FOR DEPRESSION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 122
EUROPE: DEEP BRAIN STIMULATION MARKET FOR DEPRESSION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 123
ASIA PACIFIC: DEEP BRAIN STIMULATION MARKET FOR DEPRESSION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 124
LATIN AMERICA: DEEP BRAIN STIMULATION MARKET FOR DEPRESSION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 125
OTHER DEEP BRAIN STIMULATION APPLICATIONS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 126
NORTH AMERICA: OTHER DEEP BRAIN STIMULATION APPLICATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 127
EUROPE: OTHER DEEP BRAIN STIMULATION APPLICATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 128
ASIA PACIFIC: OTHER DEEP BRAIN STIMULATION APPLICATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 129
LATIN AMERICA: OTHER DEEP BRAIN STIMULATION APPLICATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 130
NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 131
SACRAL NERVE STIMULATION MARKET FOR URINE INCONTINENCE, BY REGION, 2023–2030 (USD MILLION)
TABLE 132
NORTH AMERICA: SACRAL NERVE STIMULATION MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 133
EUROPE: SACRAL NERVE STIMULATION MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 134
ASIA PACIFIC: SACRAL NERVE STIMULATION MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 135
LATIN AMERICA: SACRAL NERVE STIMULATION MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 136
SACRAL NERVE STIMULATION MARKET FOR FECAL INCONTINENCE, BY REGION, 2023–2030 (USD MILLION)
TABLE 137
NORTH AMERICA: SACRAL NERVE STIMULATION MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 138
EUROPE: SACRAL NERVE STIMULATION MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 139
ASIA PACIFIC: SACRAL NERVE STIMULATION MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 140
LATIN AMERICA: SACRAL NERVE STIMULATION MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 141
NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 142
VAGUS NERVE STIMULATION MARKET FOR EPILEPSY, BY REGION, 2023–2030 (USD MILLION)
TABLE 143
NORTH AMERICA: VAGUS NERVE STIMULATION MARKET FOR EPILEPSY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 144
EUROPE: VAGUS NERVE STIMULATION MARKET FOR EPILEPSY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 145
ASIA PACIFIC: VAGUS NERVE STIMULATION MARKET FOR EPILEPSY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 146
LATIN AMERICA: VAGUS NERVE STIMULATION MARKET FOR EPILEPSY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 147
OTHER VAGUS NERVE STIMULATION APPLICATIONS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 148
NORTH AMERICA: OTHER VAGUS NERVE STIMULATION APPLICATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 149
EUROPE: OTHER VAGUS NERVE STIMULATION APPLICATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 150
ASIA PACIFIC: OTHER VAGUS NERVE STIMULATION APPLICATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 151
LATIN AMERICA: OTHER VAGUS NERVE STIMULATION APPLICATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 152
NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 153
GASTRIC ELECTRICAL STIMULATION MARKET FOR GASTROPARESIS, BY REGION, 2023–2030 (USD MILLION)
TABLE 154
NORTH AMERICA: GASTRIC ELECTRICAL STIMULATION MARKET FOR GASTROPARESIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 155
EUROPE: GASTRIC ELECTRICAL STIMULATION MARKET FOR GASTROPARESIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 156
ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATION MARKET FOR GASTROPARESIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 157
LATIN AMERICA: GASTRIC ELECTRICAL STIMULATION MARKET FOR GASTROPARESIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 158
GLOBAL NUMBERS OF ADULTS WITH OBESITY (BMI ≥30 KG/M2 ), BY REGION (BILLION)
TABLE 159
GASTRIC ELECTRICAL STIMULATION MARKET FOR OBESITY, BY REGION, 2023–2030 (USD MILLION)
TABLE 160
NORTH AMERICA: GASTRIC ELECTRICAL STIMULATION MARKET FOR OBESITY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 161
EUROPE: GASTRIC ELECTRICAL STIMULATION MARKET FOR OBESITY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 162
ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATION MARKET FOR OBESITY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 163
LATIN AMERICA: GASTRIC ELECTRICAL STIMULATION MARKET FOR OBESITY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 164
NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 165
TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY REGION, 2023–2030 (USD MILLION)
TABLE 166
NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 167
EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 168
ASIA PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 169
LATIN AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 170
OTHER TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION APPLICATIONS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 171
NORTH AMERICA: OTHER TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION APPLICATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 172
EUROPE: OTHER TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION APPLICATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 173
ASIA PACIFIC: OTHER TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION APPLICATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 174
LATIN AMERICA: OTHER TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION APPLICATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 175
NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 176
TRANSCRANIAL MAGNETIC STIMULATION MARKET FOR DEPRESSION, BY REGION, 2023–2030 (USD MILLION)
TABLE 177
NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATION MARKET FOR DEPRESSION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 178
EUROPE: TRANSCRANIAL MAGNETIC STIMULATION MARKET FOR DEPRESSION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 179
ASIA PACIFIC: TRANSCRANIAL MAGNETIC STIMULATION MARKET FOR DEPRESSION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 180
LATIN AMERICA: TRANSCRANIAL MAGNETIC STIMULATION MARKET FOR DEPRESSION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 181
TRANSCRANIAL MAGNETIC STIMULATION MARKET FOR MIGRAINE, BY REGION, 2023–2030 (USD MILLION)
TABLE 182
NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATION MARKET FOR MIGRAINE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 183
EUROPE: TRANSCRANIAL MAGNETIC STIMULATION MARKET FOR MIGRAINE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 184
ASIA PACIFIC: TRANSCRANIAL MAGNETIC STIMULATION MARKET FOR MIGRAINE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 185
LATIN AMERICA: TRANSCRANIAL MAGNETIC STIMULATION MARKET FOR MIGRAINE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 186
NEUROMODULATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION, BY REGION, 2023–2030 (USD MILLION)
TABLE 187
NORTH AMERICA: NEUROMODULATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 188
EUROPE: NEUROMODULATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 189
ASIA PACIFIC: NEUROMODULATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 190
LATIN AMERICA: NEUROMODULATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 191
OTHER NEUROMODULATION APPLICATIONS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 192
NORTH AMERICA: OTHER NEUROMODULATION APPLICATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 193
EUROPE: OTHER NEUROMODULATION APPLICATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 194
ASIA PACIFIC: OTHER NEUROMODULATION APPLICATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 195
LATIN AMERICA: OTHER NEUROMODULATION APPLICATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 196
NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 197
NUMBER OF HOSPITALS PER CAPITA, BY COUNTRY, 2024
TABLE 198
NEUROMODULATION MARKET FOR HOSPITALS & AMBULATORY SURGERY CENTERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 199
NORTH AMERICA: NEUROMODULATION MARKET FOR HOSPITALS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 200
EUROPE: NEUROMODULATION MARKET FOR HOSPITALS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 201
ASIA PACIFIC: NEUROMODULATION MARKET FOR HOSPITALS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 202
LATIN AMERICA: NEUROMODULATION MARKET FOR HOSPITALS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 203
NEUROMODULATION MARKET FOR CLINICS & PHYSIOTHERAPY CENTERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 204
NORTH AMERICA: NEUROMODULATION MARKET FOR CLINICS & PHYSIOTHERAPY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 205
EUROPE: NEUROMODULATION MARKET FOR CLINICS & PHYSIOTHERAPY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 206
ASIA PACIFIC: NEUROMODULATION FOR CLINICS & PHYSIOTHERAPY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 207
LATIN AMERICA: NEUROMODULATION MARKET FOR CLINICS & PHYSIOTHERAPY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 208
NEUROMODULATION MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 209
NORTH AMERICA: NEUROMODULATION MARKET FOR OTHER END USERS, 2023–2030 (USD MILLION)
TABLE 210
EUROPE: NEUROMODULATION MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 211
ASIA PACIFIC: NEUROMODULATION MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 212
LATIN AMERICA: NEUROMODULATION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 213
NEUROMODULATION MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 214
NORTH AMERICA: KEY MACROINDICATORS
TABLE 215
NORTH AMERICA: NEUROMODULATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 216
NORTH AMERICA: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 217
NORTH AMERICA: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 218
NORTH AMERICA: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 219
NORTH AMERICA: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 220
NORTH AMERICA: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 221
NORTH AMERICA: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 222
NORTH AMERICA: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 223
NORTH AMERICA: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 224
NORTH AMERICA: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 225
NORTH AMERICA: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 226
US: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 227
US: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 228
US: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 229
US: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 230
US: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 231
US: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 232
US: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 233
US: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 234
US: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 235
US: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 236
CANADA: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 237
CANADA: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 238
CANADA: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 239
CANADA: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 240
CANADA: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 241
CANADA: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 242
CANADA: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 243
CANADA: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 244
CANADA: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 245
CANADA: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 246
EUROPE: KEY MACROINDICATORS
TABLE 247
EUROPE: NEUROMODULATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 248
EUROPE: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 249
EUROPE: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 250
EUROPE: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 251
EUROPE: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 252
EUROPE: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 253
EUROPE: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 254
EUROPE: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 255
EUROPE: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 256
EUROPE: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 257
EUROPE: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 258
GERMANY: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 259
GERMANY: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 260
GERMANY: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 261
GERMANY: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 262
GERMANY: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 263
GERMANY: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 264
GERMANY: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 265
GERMANY: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 266
GERMANY: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 267
GERMANY: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 268
FRANCE: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 269
FRANCE: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 270
FRANCE: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 271
FRANCE: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 272
FRANCE: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 273
FRANCE: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 274
FRANCE: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 275
FRANCE: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 276
FRANCE: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 277
FRANCE: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 278
UK: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 279
UK: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 280
UK: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 281
UK: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 282
UK: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 283
UK: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 284
UK: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 285
UK: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 286
UK: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 287
UK: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 288
ITALY: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 289
ITALY: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 290
ITALY: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 291
ITALY: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 292
ITALY: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 293
ITALY: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 294
ITALY: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 295
ITALY: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 296
ITALY: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 297
ITALY: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 298
SPAIN: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 299
SPAIN: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 300
SPAIN: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 301
SPAIN: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 302
SPAIN: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 303
SPAIN: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 304
SPAIN: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 305
SPAIN: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 306
SPAIN: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 307
SPAIN: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 308
RUSSIA: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 309
RUSSIA: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 310
RUSSIA: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 311
RUSSIA: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 312
RUSSIA: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 313
RUSSIA: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 314
RUSSIA: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 315
RUSSIA: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 316
RUSSIA: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 317
RUSSIA: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 318
REST OF EUROPE: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 319
REST OF EUROPE: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 320
REST OF EUROPE: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 321
REST OF EUROPE: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 322
REST OF EUROPE: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 323
REST OF EUROPE: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 324
REST OF EUROPE: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 325
REST OF EUROPE: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 326
REST OF EUROPE: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 327
REST OF EUROPE: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 328
ASIA PACIFIC: KEY MACROINDICATORS
TABLE 329
ASIA PACIFIC: NEUROMODULATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 330
ASIA PACIFIC: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 331
ASIA PACIFIC: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 332
ASIA PACIFIC: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 333
ASIA PACIFIC: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 334
ASIA PACIFIC: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 335
ASIA PACIFIC: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 336
ASIA PACIFIC: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 337
ASIA PACIFIC: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 338
ASIA PACIFIC: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 339
ASIA PACIFIC: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 340
CHINA: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 341
CHINA: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 342
CHINA: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 343
CHINA: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 344
CHINA: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 345
CHINA: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 346
CHINA: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 347
CHINA: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 348
CHINA: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 349
CHINA: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 350
JAPAN: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 351
JAPAN: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 352
JAPAN: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 353
JAPAN: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 354
JAPAN: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 355
JAPAN: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 356
JAPAN: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 357
JAPAN: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 358
JAPAN: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 359
JAPAN: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 360
INDIA: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 361
INDIA: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 362
INDIA: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 363
INDIA: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 364
INDIA: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 365
INDIA: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 366
INDIA: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 367
INDIA: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 368
INDIA: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 369
INDIA: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 370
AUSTRALIA: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 371
AUSTRALIA: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 372
AUSTRALIA: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 373
AUSTRALIA: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 374
AUSTRALIA: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 375
AUSTRALIA: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 376
AUSTRALIA: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 377
AUSTRALIA: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 378
AUSTRALIA: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 379
AUSTRALIA: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 380
REST OF ASIA PACIFIC: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 381
REST OF ASIA PACIFIC: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 382
REST OF ASIA PACIFIC: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 383
REST OF ASIA PACIFIC: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 384
REST OF ASIA PACIFIC: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 385
REST OF ASIA PACIFIC: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 386
REST OF ASIA PACIFIC: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 387
REST OF ASIA PACIFIC: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 388
REST OF ASIA PACIFIC: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 389
REST OF ASIA PACIFIC: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 390
LATIN AMERICA: KEY MACROINDICATORS
TABLE 391
LATIN AMERICA: NEUROMODULATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 392
LATIN AMERICA: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 393
LATIN AMERICA: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 394
LATIN AMERICA: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 395
LATIN AMERICA: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 396
LATIN AMERICA: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 397
LATIN AMERICA: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 398
LATIN AMERICA: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 399
LATIN AMERICA: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 400
LATIN AMERICA: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 401
LATIN AMERICA: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 402
BRAZIL: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 403
BRAZIL: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 404
BRAZIL: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 405
BRAZIL: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 406
BRAZIL: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 407
BRAZIL: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 408
BRAZIL: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 409
BRAZIL: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 410
BRAZIL: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 411
BRAZIL: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 412
MEXICO: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 413
MEXICO: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 414
MEXICO: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 415
MEXICO: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 416
MEXICO: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 417
MEXICO: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 418
MEXICO: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 419
MEXICO: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 420
MEXICO: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 421
MEXICO: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 422
REST OF LATIN AMERICA: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 423
REST OF LATIN AMERICA: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 424
REST OF LATIN AMERICA: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 425
REST OF LATIN AMERICA: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 426
REST OF LATIN AMERICA: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 427
REST OF LATIN AMERICA: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 428
REST OF LATIN AMERICA: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 429
REST OF LATIN AMERICA: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 430
REST OF LATIN AMERICA: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 431
REST OF LATIN AMERICA: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 432
MIDDLE EAST & AFRICA: KEY MACROINDICATORS
TABLE 433
MIDDLE EAST & AFRICA: NEUROMODULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 434
MIDDLE EAST & AFRICA: NEUROMODULATION MARKET, BY STIMULATION TYPE, 2023–2030 (USD MILLION)
TABLE 435
MIDDLE EAST & AFRICA: NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 436
MIDDLE EAST & AFRICA: NEUROMODULATION MARKET FOR DEEP BRAIN STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 437
MIDDLE EAST & AFRICA: NEUROMODULATION MARKET FOR SACRAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 438
MIDDLE EAST & AFRICA: NEUROMODULATION MARKET FOR VAGUS NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 439
MIDDLE EAST & AFRICA: NEUROMODULATION MARKET FOR GASTRIC ELECTRICAL STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 440
MIDDLE EAST & AFRICA: NEUROMODULATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 441
MIDDLE EAST & AFRICA: NEUROMODULATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 442
MIDDLE EAST & AFRICA: NEUROMODULATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 443
MAJOR STRATEGIES DEPLOYED BY KEY PLAYERS IN NEUROMODULATION MARKET, JANUARY 2022–JULY 2025
TABLE 444
NEUROMODULATION MARKET: DEGREE OF COMPETITION
TABLE 445
NEUROMODULATION MARKET: REGION FOOTPRINT
TABLE 446
NEUROMODULATION MARKET: TECHNOLOGY FOOTPRINT
TABLE 447
NEUROMODULATION MARKET: STIMULATION TYPE FOOTPRINT
TABLE 448
NEUROMODULATION MARKET: END-USER FOOTPRINT
TABLE 449
NEUROMODULATION MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
TABLE 450
NEUROMODULATION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY TECHNOLOGY AND REGION
TABLE 451
NEUROMODULATION MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025
TABLE 452
NEUROMODULATION MARKET: DEALS, JANUARY 2022–JULY 2025
TABLE 453
MEDTRONIC: COMPANY OVERVIEW
TABLE 454
MEDTRONIC: PRODUCTS OFFERED
TABLE 455
MEDTRONIC: PRODUCT APPROVALS, JANUARY 2022–JULY 2025
TABLE 456
BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
TABLE 457
BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
TABLE 458
BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS, JANUARY 2022–JULY 2025
TABLE 459
BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022–JULY 2025
TABLE 460
ABBOTT: COMPANY OVERVIEW
TABLE 461
ABBOTT: PRODUCTS OFFERED
TABLE 462
ABBOTT: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025
TABLE 463
LIVANOVA PLC: COMPANY OVERVIEW
TABLE 464
LIVANOVA PLC: PRODUCTS OFFERED
TABLE 465
LIVANOVA PLC: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025
TABLE 466
NEVRO CORP.: COMPANY OVERVIEW
TABLE 467
NEVRO CORP.: PRODUCTS OFFERED
TABLE 468
NEVRO CORP.: PRODUCT APPROVALS, JANUARY 2022–JULY 2025
TABLE 469
NEVRO CORP.: DEALS, JANUARY 2022–JULY 2025
TABLE 470
NEUROPACE, INC.: COMPANY OVERVIEW
TABLE 471
NEUROPACE, INC.: PRODUCTS OFFERED
TABLE 472
BIOVENTUS: COMPANY OVERVIEW
TABLE 473
BIOVENTUS: PRODUCTS OFFERED
TABLE 474
BIOVENTUS: PRODUCT APPROVALS, JANUARY 2022–JULY 2025
TABLE 475
ELECTROCORE, INC.: COMPANY OVERVIEW
TABLE 476
ELECTROCORE, INC.: PRODUCTS OFFERED
TABLE 477
ELECTROCORE, INC.: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025
TABLE 478
ELECTROCORE, INC.: DEALS, JANUARY 2022–JULY 2025
TABLE 479
HELIUS MEDICAL TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 480
HELIUS MEDICAL TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 481
HELIUS MEDICAL TECHNOLOGIES, INC.: DEALS, JANUARY 2022–JULY 2025
TABLE 482
NEURONETICS: COMPANY OVERVIEW
TABLE 483
NEURONETICS: PRODUCTS OFFERED
TABLE 484
NEURONETICS: PRODUCT APPROVALS, JANUARY 2022–JULY 2025
TABLE 485
NEURONETICS: DEALS, JANUARY 2022–JULY 2025
TABLE 486
NEUROSIGMA, INC.: COMPANY OVERVIEW
TABLE 487
SOTERIX MEDICAL INC.: COMPANY OVERVIEW
TABLE 488
SYNAPSE BIOMEDICAL INC.: COMPANY OVERVIEW
TABLE 489
ALEVA NEUROTHERAPEUTICS: COMPANY OVERVIEW
TABLE 490
THERANICA BIO-ELECTRONICS LTD.: COMPANY OVERVIEW
TABLE 491
GIMER MEDICAL: COMPANY OVERVIEW
TABLE 492
NALU MEDICAL, INC.: COMPANY OVERVIEW
TABLE 493
MICROTRANSPONDER INC.: COMPANY OVERVIEW
TABLE 494
MAGSTIM: COMPANY OVERVIEW
TABLE 495
AMBER THERAPEUTICS: COMPANY OVERVIEW
TABLE 496
TVNS TECHNOLOGIES GMBH: COMPANY OVERVIEW
TABLE 497
BIOWAVE: COMPANY OVERVIEW
TABLE 498
BIOTRONIK: COMPANY OVERVIEW
TABLE 499
SALUDA MEDICAL PTY LTD.: COMPANY OVERVIEW
TABLE 500
SPR: COMPANY OVERVIEW
FIGURE 1
NEUROMODULATION MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2
NEUROMODULATION MARKET: YEARS CONSIDERED
FIGURE 3
NEUROMODULATION MARKET: RESEARCH DESIGN
FIGURE 4
NEUROMODULATION MARKET: KEY DATA FROM SECONDARY SOURCES
FIGURE 5
LIST OF PRIMARY SOURCES IN NEUROMODULATION MARKET
FIGURE 6
NEUROMODULATION MARKET: BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 7
KEY INSIGHTS FROM PRIMARY EXPERTS IN NEUROMODULATION MARKET
FIGURE 8
REVENUE ESTIMATION OF KEY PLAYERS IN NEUROMODULATION MARKET
FIGURE 9
CAGR PROJECTIONS INNEUROMODULATION MARKET
FIGURE 10
NEUROMODULATION MARKET: TOP-DOWN APPROACH
FIGURE 11
NEUROMODULATION MARKET: DATA TRIANGULATION
FIGURE 12
PARAMETRIC ASSUMPTIONS IN NEUROMODULATION MARKET
FIGURE 13
NEUROMODULATION MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 14
NEUROMODULATION MARKET, BY STIMULATION TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 15
NEUROMODULATION MARKET FOR SPINAL CORD STIMULATION, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 16
NEUROMODULATION MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 17
REGIONAL SNAPSHOT OF NEUROMODULATION MARKET
FIGURE 18
RISE IN GERIATRIC POPULATION AND HIGH DEMAND FOR ADVANCED NEUROMODULATION THERAPIES TO DRIVE MARKET
FIGURE 19
CHINA AND HOSPITALS & AMBULATORY SURGERY CENTERS COMMANDED SIGNIFICANT MARKET SHARES IN 2024
FIGURE 20
CHINA TO ACCOUNT FOR HIGHEST CAGR DURING STUDY PERIOD
FIGURE 21
ASIA PACIFIC TO EXHIBIT FASTEST GROWTH DURING FORECAST PERIOD
FIGURE 22
NEUROMODULATION MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 23
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS IN NEURMODULATION MARKET
FIGURE 24
NEUROMODULATION MARKET: VALUE CHAIN ANALYSIS
FIGURE 25
NEUROMODULATION MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 26
NEUROMODULATION MARKET: ECOSYSTEM ANALYSIS
FIGURE 27
FUNDING AND NUMBER OF DEALS IN NEUROMODULATION MARKET, 2021–2024 (USD MILLION)
FIGURE 28
NEUROMODULATION MARKET: TOP 10 PATENT APPLICANTS/OWNERS AND NUMBER OF PATENTS APPLIED/GRANTED, 2015–2024
FIGURE 29
NEUROMODULATION MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 30
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER
FIGURE 31
KEY BUYING CRITERIA, BY END USER
FIGURE 32
IMPACT OF AI ON NEUROMODULATION MARKET
FIGURE 33
NORTH AMERICA: NEUROMODULATION MARKET SNAPSHOT
FIGURE 34
NUMBER OF PATIENTS WITH ALZHEIMER’S IN US, 2020–2060 (MILLION)
FIGURE 35
ASIA PACIFIC: NEUROMODULATION MARKET SNAPSHOT
FIGURE 36
REVENUE ANALYSIS OF KEY PLAYERS IN NEUROMODULATION MARKET, 2020–2024 (USD MILLION)
FIGURE 37
MARKET SHARE ANALYSIS OF KEY PLAYERS IN NEUROMODULATION MARKET (2024)
FIGURE 38
NEUROMODULATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 39
NEUROMODULATION MARKET: COMPANY FOOTPRINT
FIGURE 40
NEUROMODULATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 41
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND FIVE-YEAR STOCK BETA OF KEY VENDORS
FIGURE 42
EV/EBITDA OF KEY VENDORS
FIGURE 43
NEUROMODULATION MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 44
MEDTRONIC: COMPANY SNAPSHOT
FIGURE 45
BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
FIGURE 46
ABBOTT: COMPANY SNAPSHOT
FIGURE 47
LIVANOVA PLC: COMPANY SNAPSHOT
FIGURE 48
NEVRO CORP.: COMPANY SNAPSHOT
FIGURE 49
NEUROPACE, INC.: COMPANY SNAPSHOT
FIGURE 50
BIOVENTUS: COMPANY SNAPSHOT
FIGURE 51
ELECTROCORE, INC.: COMPANY SNAPSHOT
FIGURE 52
HELIUS MEDICAL TECHNOLOGIES, INC.: COMPANY SNAPSHOT
FIGURE 53
NEURONETICS: COMPANY SNAPSHOT
Peter
Jul, 2026
After reviewing the Neuromodulation Market report, I found the breakdown of implantable devices and chronic pain applications especially useful for understanding how hospitals are prioritizing long-term neurostimulation therapies..
Zachary
Jul, 2026
I went through the Neuromodulation Market analysis to compare regional adoption trends, and the report gave me a much clearer view of how reimbursement and regulatory pathways are shaping commercial expansion..
Kyle
Jul, 2026
While assessing opportunities in the Neuromodulation Market, I noticed the report provided practical insight into competitive positioning and product innovation strategies that are influencing investment decisions across neurotechnology companies..